South Korea · Delayed Price · Currency is KRW EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 209.08 billion. The enterprise value is 342.10 billion.
| Market Cap | 209.08B |
| Enterprise Value | 342.10B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Mar 9, 2026 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -0.82% in one year.
| Current Share Class | 33.08M |
| Shares Outstanding | 33.08M |
| Shares Change (YoY) | -0.82% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 7.40% |
| Float | 16.04M |
Valuation Ratios
The trailing PE ratio is 5.25 and the forward PE ratio is 4.89.
| PE Ratio | 5.25 |
| Forward PE | 4.89 |
| PS Ratio | 0.40 |
| PB Ratio | 1.58 |
| P/TBV Ratio | 4.54 |
| P/FCF Ratio | 5.88 |
| P/OCF Ratio | 4.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.53, with an EV/FCF ratio of 9.62.
| EV / Earnings | 8.59 |
| EV / Sales | 0.65 |
| EV / EBITDA | 5.53 |
| EV / EBIT | 6.44 |
| EV / FCF | 9.62 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.34.
| Current Ratio | 1.24 |
| Quick Ratio | 0.74 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 5.00 |
| Interest Coverage | 8.58 |
Financial Efficiency
Return on equity (ROE) is 38.00% and return on invested capital (ROIC) is 15.88%.
| Return on Equity (ROE) | 38.00% |
| Return on Assets (ROA) | 9.66% |
| Return on Invested Capital (ROIC) | 15.88% |
| Return on Capital Employed (ROCE) | 25.10% |
| Weighted Average Cost of Capital (WACC) | 5.48% |
| Revenue Per Employee | 814.01M |
| Profits Per Employee | 61.74M |
| Employee Count | 645 |
| Asset Turnover | 1.53 |
| Inventory Turnover | 6.36 |
Taxes
In the past 12 months, EASY BIO,Inc. has paid 14.51 billion in taxes.
| Income Tax | 14.51B |
| Effective Tax Rate | 25.71% |
Stock Price Statistics
The stock price has increased by +16.18% in the last 52 weeks. The beta is 0.67, so EASY BIO,Inc.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +16.18% |
| 50-Day Moving Average | 6,249.40 |
| 200-Day Moving Average | 6,673.15 |
| Relative Strength Index (RSI) | 48.80 |
| Average Volume (20 Days) | 93,243 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 525.04 billion and earned 39.82 billion in profits. Earnings per share was 1,203.70.
| Revenue | 525.04B |
| Gross Profit | 138.27B |
| Operating Income | 53.12B |
| Pretax Income | 56.44B |
| Net Income | 39.82B |
| EBITDA | 61.91B |
| EBIT | 53.12B |
| Earnings Per Share (EPS) | 1,203.70 |
Balance Sheet
The company has 49.76 billion in cash and 177.65 billion in debt, with a net cash position of -127.89 billion or -3,865.94 per share.
| Cash & Cash Equivalents | 49.76B |
| Total Debt | 177.65B |
| Net Cash | -127.89B |
| Net Cash Per Share | -3,865.94 |
| Equity (Book Value) | 132.09B |
| Book Value Per Share | 3,837.73 |
| Working Capital | 40.97B |
Cash Flow
In the last 12 months, operating cash flow was 44.81 billion and capital expenditures -9.26 billion, giving a free cash flow of 35.55 billion.
| Operating Cash Flow | 44.81B |
| Capital Expenditures | -9.26B |
| Depreciation & Amortization | 8.80B |
| Net Borrowing | -3.84B |
| Free Cash Flow | 35.55B |
| FCF Per Share | 1,074.69 |
Margins
Gross margin is 26.33%, with operating and profit margins of 10.12% and 7.58%.
| Gross Margin | 26.33% |
| Operating Margin | 10.12% |
| Pretax Margin | 10.75% |
| Profit Margin | 7.58% |
| EBITDA Margin | 11.79% |
| EBIT Margin | 10.12% |
| FCF Margin | 6.77% |
Dividends & Yields
This stock pays an annual dividend of 250.00, which amounts to a dividend yield of 3.91%.
| Dividend Per Share | 250.00 |
| Dividend Yield | 3.91% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 21.44% |
| Buyback Yield | 0.82% |
| Shareholder Yield | 4.73% |
| Earnings Yield | 19.05% |
| FCF Yield | 17.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Dec 21, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.78 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.78 |
| Piotroski F-Score | 7 |